Skip to main content
Van Morris, MD, Oncology, Houston, TX

Van Morris MD

Gastrointestinal Cancer, Hematologic Oncology


MD

Join to View Full Profile
  • 1515 Holcombe BlvdHouston, TX 77030

  • Phone+1 713-794-5446

Dr. Morris is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Texas Health Science Center at Houston/M D Anderson Cancer Center
    University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2011 - 2014
  • Duke University Hospital
    Duke University HospitalResidency, Internal Medicine, 2008 - 2011
  • University of Tennessee Health Science Center College of Medicine
    University of Tennessee Health Science Center College of MedicineClass of 2008

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • AZ State Medical License
    AZ State Medical License 2023 - 2026
  • GA State Medical License
    GA State Medical License 2023 - 2026
  • TN State Medical License
    TN State Medical License 2023 - 2026
  • TX State Medical License
    TX State Medical License 2012 - 2026
  • AL State Medical License
    AL State Medical License 2023 - 2025
  • LA State Medical License
    LA State Medical License 2023 - 2025
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Hematology
    American Board of Internal Medicine Hematology
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Anti-EGFR Resistant Clones Decay Exponentially After Progression: Implications for Anti-EGFR Re-Challenge  
    B Kee, N Garg, M J Overman, V K Morris, B Johnson, J Wu, J H Strickler, S Kopetz, X Liu, D S Hong, Annals of Oncology

Lectures

  • NRG-GI005 (COBRA): Phase II/III study of circulating tumor DNA as a predictive biomarker in adjuvant chemotherapy in patients with stage II colon cancer. 
    ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/25/2020
  • Are We Moving the Needle in Advanced Colorectal and Anal Cancers? 
    ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/25/2020

Press Mentions

  • MD Anderson Unveils Key Research Breakthroughs: Highlights from March 12, 2025
    MD Anderson Unveils Key Research Breakthroughs: Highlights from March 12, 2025March 12th, 2025
  • MD Anderson Research Highlights for March 12, 2025
    MD Anderson Research Highlights for March 12, 2025March 12th, 2025
  • Gastrointestinal Medical Oncologist and Researcher Driven to Help Patients Live Longer
    Gastrointestinal Medical Oncologist and Researcher Driven to Help Patients Live LongerOctober 8th, 2024
  • Join now to see all

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: